Search research articles
Contact Us
Filters
Showing results (901-910 of 987) with videos related to
Page
of 99
Sort By:
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals
|
September 24, 2020
The Use of Tranexamic Acid in Tactical Combat Casualty Care: TCCC Proposed Change 20-02
Brendon Drew, Jonathan D Auten, Andrew P Cap, et al.
Obesity (Silver Spring, Md.)
|
November 3, 2023
Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study
Jennifer L Miller, Evelien Gevers, Nicola Bridges, et al.
The Plant Cell
|
November 15, 2015
Transcriptional Dynamics Driving MAMP-Triggered Immunity and Pathogen Effector-Mediated Immunosuppression in Arabidopsis Leaves Following Infection with Pseudomonas syringae pv tomato DC3000
Laura A Lewis, Krzysztof Polanski, Marta de Torres-Zabala, et al.
The Lancet. Oncology
|
March 16, 2013
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial
Viviana Galimberti, Bernard F Cole, Stefano Zurrida, et al.
Science Advances
|
November 14, 2025
Structural and epistatic regulatory variants cause hallmark white spotting in cattle
Swati Jivanji, Emma Wilkinson, Lijing Tang, et al.
Alimentary Pharmacology & Therapeutics
|
May 6, 2022
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels
Samuel A L Hall, Gareth S Burns, Despina Anagnostou, et al.
Physical Review Letters
|
April 18, 2025
Measurements of Pion and Muon Nuclear Capture at Rest on Argon in the LArIAT Experiment
M A Hernandez-Morquecho, R Acciarri, J Asaadi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 3, 2026
Diazoxide Choline Extended-Release Tablets in Prader-Willi Syndrome: A Randomized, Double-Blind, Withdrawal Period Study
Jennifer L Miller, Nicola Bridges, Eric I Felner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 15, 2024
High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy
Simon J Hume, Danny K Wong, Man-Fung Yuen, et al.
The Journal of Infectious Diseases
|
September 15, 2022
Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways
Samuel A L Hall, Gareth S Burns, Benjamin J Mooney, et al.
Page
of 99
Search research articles
Search
Showing results (901-910 of 987) with videos related to
Sort By:
Page
of 99
Journal of Special Operations Medicine : a Peer Reviewed Journal for SOF Medical Professionals
|
September 24, 2020
The Use of Tranexamic Acid in Tactical Combat Casualty Care: TCCC Proposed Change 20-02
Brendon Drew, Jonathan D Auten, Andrew P Cap, et al.
Obesity (Silver Spring, Md.)
|
November 3, 2023
Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: results from long-term open-label study
Jennifer L Miller, Evelien Gevers, Nicola Bridges, et al.
The Plant Cell
|
November 15, 2015
Transcriptional Dynamics Driving MAMP-Triggered Immunity and Pathogen Effector-Mediated Immunosuppression in Arabidopsis Leaves Following Infection with Pseudomonas syringae pv tomato DC3000
Laura A Lewis, Krzysztof Polanski, Marta de Torres-Zabala, et al.
The Lancet. Oncology
|
March 16, 2013
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial
Viviana Galimberti, Bernard F Cole, Stefano Zurrida, et al.
Science Advances
|
November 14, 2025
Structural and epistatic regulatory variants cause hallmark white spotting in cattle
Swati Jivanji, Emma Wilkinson, Lijing Tang, et al.
Alimentary Pharmacology & Therapeutics
|
May 6, 2022
Stopping nucleot(s)ide analogues in non-cirrhotic HBeAg-negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels
Samuel A L Hall, Gareth S Burns, Despina Anagnostou, et al.
Physical Review Letters
|
April 18, 2025
Measurements of Pion and Muon Nuclear Capture at Rest on Argon in the LArIAT Experiment
M A Hernandez-Morquecho, R Acciarri, J Asaadi, et al.
The Journal of Clinical Endocrinology and Metabolism
|
January 3, 2026
Diazoxide Choline Extended-Release Tablets in Prader-Willi Syndrome: A Randomized, Double-Blind, Withdrawal Period Study
Jennifer L Miller, Nicola Bridges, Eric I Felner, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 15, 2024
High end-of-treatment hepatitis B core-related antigen levels predict hepatitis flare after stopping nucleot(s)ide analogue therapy
Simon J Hume, Danny K Wong, Man-Fung Yuen, et al.
The Journal of Infectious Diseases
|
September 15, 2022
Hepatitis B Virus Flares After Nucleot(s)ide Analogue Cessation Are Associated With Activation of Toll-Like Receptor Signaling Pathways
Samuel A L Hall, Gareth S Burns, Benjamin J Mooney, et al.
Page
of 99